These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1914074)

  • 1. Chemotherapy in malignant mesothelioma: a review.
    Krarup-Hansen A; Hansen HH
    Cancer Chemother Pharmacol; 1991; 28(5):319-30. PubMed ID: 1914074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of chemotherapy trials for malignant mesothelioma.
    Ryan CW; Herndon J; Vogelzang NJ
    Chest; 1998 Jan; 113(1 Suppl):66S-73S. PubMed ID: 9438693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for malignant pleural mesothelioma.
    Janne PA
    Clin Lung Cancer; 2003 Sep; 5(2):98-106. PubMed ID: 14596692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy and serum hyaluronic acid levels in malignant peritoneal mesothelioma.
    Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Tanimura H; Tsubota YT
    Hepatogastroenterology; 2004; 51(58):1073-83. PubMed ID: 15239250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic drug therapy of malignant pleural mesothelioma.
    Ardizzoni A; Grossi F; Pennucci MC
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):236-40. PubMed ID: 9689814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pleural mesothelioma: two cases in first degree relatives.
    Wilkins A; Popat S; Hughes S; O'Brien M
    Lung Cancer; 2007 Sep; 57(3):407-9. PubMed ID: 17400330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review on clinical trials of targeted treatments in malignant mesothelioma.
    Jakobsen JN; Sørensen JB
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):1-15. PubMed ID: 21553148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of tumor response in malignant pleural mesothelioma.
    Ceresoli GL; Chiti A; Zucali PA; Cappuzzo F; De Vincenzo F; Cavina R; Rodari M; Poretti D; Lutman FR; Santoro A
    Cancer Treat Rev; 2007 Oct; 33(6):533-41. PubMed ID: 17764849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT, RECIST, and malignant pleural mesothelioma.
    Nowak AK
    Lung Cancer; 2005 Jul; 49 Suppl 1():S37-40. PubMed ID: 15950799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of sarcomatoid malignant peritoneal mesothelioma responding to combination chemotherapy of cyclophosphamide, vincristine, adriamycin and dacarbazine(CYVADIC)].
    Kusama T; Kodaka T; Tsunemine H; Akasaka H; Koizumi N; Fujimoto K; Sakano S; Ito R; Kondo T; Kitazawa S; Yamamura H; Takahashi K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):475-8. PubMed ID: 19295275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
    Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
    Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
    Chahinian AP; Mandeli JP; Gluck H; Naim H; Teirstein AS; Holland JF
    J Surg Oncol; 1998 Feb; 67(2):104-11. PubMed ID: 9486781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant peritoneal mesothelioma in two pediatric patients: MR imaging findings.
    Haliloglu M; Hoffer FA; Fletcher BD
    Pediatr Radiol; 2000 Apr; 30(4):251-5. PubMed ID: 10789904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed-cisplatin combination in mesothelioma.
    Reck M; Gatzemeier U
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
    Ellis P; Davies AM; Evans WK; Haynes AE; Lloyd NS;
    J Thorac Oncol; 2006 Jul; 1(6):591-601. PubMed ID: 17409924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial.
    Calabrò L; Morra A; Fonsatti E; Cutaia O; Amato G; Giannarelli D; Di Giacomo AM; Danielli R; Altomonte M; Mutti L; Maio M
    Lancet Oncol; 2013 Oct; 14(11):1104-1111. PubMed ID: 24035405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
    Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD
    Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
    Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
    Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.